Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
| Actual shortage: | 15 (2%) | |
| Anticipated shortage: | 4 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
83 (9%) |
|
Overdue reports |
1 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-AMOXICILLIN | 500MG | CAPSULE | Resolved | 2017-04-07 | 2019-10-03 | 5972 |
| MYLAN-BECLO AQ | 50MCG | METERED-DOSE AEROSOL SUSPENSION | Resolved | 2019-10-01 | 2019-10-09 | 95088 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Resolved | 2019-04-03 | 2019-10-16 | 80452 |
| MYLAN-VERAPAMIL | 120MG | TABLET | Resolved | 2019-07-03 | 2019-10-16 | 88302 |
| MYLAN-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-09-26 | 2019-10-23 | 94770 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2019-01-15 | 2019-10-29 | 72303 |
| MYLAN-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-09 | 2019-11-13 | 88985 |
| MYLAN-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-07-29 | 2019-11-13 | 90110 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-01-22 | 2020-01-09 | 36919 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-12-14 | 2020-01-09 | 33010 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-10-01 | 2020-01-13 | 95097 |
| MYLAN-ACYCLOVIR | 400MG | TABLET | Resolved | 2019-11-12 | 2020-01-17 | 98539 |
| MYLAN-TADALAFIL | 5MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94761 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-07 | 2020-01-17 | 91047 |
| MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Resolved | 2017-09-22 | 2020-01-21 | 23166 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-08-07 | 2020-01-23 | 91044 |
| CLARUS | 40MG | CAPSULE | Avoided shortage | 2020-01-24 | 2020-01-28 | 104181 |
| MYLAN-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-11-12 | 2020-01-29 | 98529 |
| MYLAN-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-11-12 | 2020-01-29 | 98534 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-01-28 | 2020-02-12 | 104518 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |